Table III.

Genes down-regulated by BRs in WT

Gene Name	Accession No.	Function or Comment	Affymetrix No.	det2		WT
				Amplified	No-Amp.	Amplified	No-Amp.
				FC ± se	FC ± se	FC ±se	FC ± se
CYP79B2	AF069495	Cytochrome P450	20479_i_at	−0.4 ± 0.70	−0.4 ± 0.68	−1.6 ± 0.35	−2.2 ± 0.05
CYP81D8	AL035601/F6G17.20	Cytochrome P450	14032_at	−2.0 ± 0.50	−0.7 ± 1.07	−3.7 ± 0.20	−1.9 ± 0.15
4HPPD	AF047834	4-Hydroxyphenylpyruvate dioxygenase	15669_s_at	−2.4 ± 0.30	−2.3 ± 0.30	−6.9 ± 1.60	−3.0 ± 0.30
CHI	M86358	Chalcone isomerase	20413_at	−1.4 ± 0.15	−1.3 ± 0.12	−2.2 ± 0.05	−2.3 ± 0.45
BRI1	AF017056	BRI1	20209_at	−1.8 ± 0.06	−1.9 ± 0.13	−2.0 ± 0.05	−2.0 ± 0.20
Eli3-1	X67816	Cinnamyl-alcohol dehydrogenase	13242_at	−1.9 ± 0.25	−1.9 ± 0.15	−1.7 ± 0.00	−2.1 ± 0.05
BRD13	AL021713/T9A21.60	Putative protein	13514_s_at	−1.9 ± 0.74	−1.8 ± 0.03	−4.0 ± 0.50	−2.0 ± 0.35
BRD14	AC006085/F11M15.3	Putative Ser/Thr protein kinase	16878_at	−3.3 ± 0.56	−1.8 ± 0.74	−4.0 ± 0.10	−1.8 ± 0.00
BRD15	AC012562/F17O14.23	Osmotic stress-inducible kinase like-protein	13246_at	−1.8 ± 0.39	−0.6 ± 0.83	−3.8 ± 1.10	−1.9 ± 0.70
BRD16	AL049480/F14M19.60	Putative pathogenesis-related protein	18755_at	−2.1 ± 0.38	−2.0 ± 0.68	−2.6 ± 0.50	−2.0 ± 0.25
BRD17	AL033545/F7K2.50	Extensin-like protein	12115_at	−2.2 ± 0.19	−1.8 ± 0.10	−2.4 ± 0.25	−2.3 ± 0.05
BRD18	AC005662/F13H10.7	Putative embryo-abundant protein	14083_at	−2.0 ± 0.15	−1.8 ± 0.27	−2.4 ± 0.15	−2.2 ± 0.15
BRD19	Y12776	Late embryogenesis-abundant protein like-protein	18594_at	−1.5 ± 0.09	−1.6 ± 0.09	−2.1 ± 0.05	−2.0 ± 0.00
BRD20	AL021811/F10M6.70	Putative protein	14574_at	−2.8 ± 0.38	−2.4 ± 0.52	−1.8 ± 0.15	−2.2 ± 0.15
BRD21	AC007661/T8P21.9	Putative protein	15487_at	−1.6 ± 0.12	−1.6 ± 0.29	−1.8 ± 0.55	−2.1 ± 0.05

When genes have names on publications or on database, we adopted their names. Otherwise, we designed genes from BRD13 to BRD21. Amplified and No-Amp., before and after signal amplification with antibody, respectively.